No Clinically Significant Pharmacokinetic Interactions Between Dolutegravir and Daclatasvir in Healthy Adult Subjects
BMC Infectious Diseases - United Kingdom
doi 10.1186/s12879-016-1629-5
Full Text
Open PDFAbstract
Available in full text
Categories
Date
July 22, 2016
Authors
Publisher
Springer Science and Business Media LLC